RESPIRATORY SUMMIT:
New Perspectives in Respiratory Diseases
Respiratory diseases account for a huge burden of morbidity and mortality globally, affecting hundreds of millions of people and leading to a huge health care workload, as well as an enormous, but often unrecognised, impact on society.
There are reasons to be optimistic for the future with developments in understanding the mechanisms of disease leading to insights into new treatment options. An increased recognition of the ability to deliver phenotype specific personalised care is leading to breakthroughs in management with life changing impacts for our patients.
We are delighted to be able to lead this new course. We aim to look at 4 of the most common and burdensome diseases: COPD, asthma, idiopathic pulmonary fibrosis (IPF) and bronchiectasis. The course will provide state of the art updates into underpinning disease mechanisms, new approaches to diagnosis and phenotyping, the impact and efficacy of current treatments and how to holistically manage patients.
We have gathered a group of world class lecturers, all of whom are recognised as global experts, leading the way through research into these lung diseases. They will provide you with the information you need to take your ability to manage these common respiratory diseases to the next level. We aim to give you the knowledge to apply the latest research and understandings and stimulate you to ask further questions to generate more knowledge.
This course will be useful for: pulmonologists, respiratory scientists, medical scientific liaison officers, advanced respiratory healthcare practitioners.
At the end of this course, you will understand:
• The pathophysiology of COPD.
• The science underpinning our understanding of exacerbations of COPD and treatments.
• How our current airways treatments work, their strengths, and limitations.
• New data on biologic therapies in airways disease and their potential for the future.
• How respiratory disease affects other organs and how best to recognise and manage this.
• Advances in the diagnosis and management of IPF and future treatments.
• How to diagnose and manage bronchiectasis.
• The latest science on inhaler technology and drug delivery.
• How to take a palliative approach with respiratory patients.
This course will be held at the Royal College of Physicians in London and will be approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 11 category 1 (external) CPD/CME credit(s).
The RCP has state of the art facilities and provides a unique venue for medical education.